Mucin modulates phage infection dynamics and biofilm formation in enteropathogenic Yersinia enterocolitica

This study demonstrates that mucins significantly modulate the infection dynamics and biofilm formation of the enteropathogen *Yersinia enterocolitica* by enhancing phage replication and acting as a nutrient source, while also driving the evolution of bacterial resistance through mutations in virulence and regulatory genes, thereby highlighting the critical role of mucosal environments in shaping phage-host interactions for therapeutic applications.

The Gist

The Big Picture: A Battle in the "Slime Layer"

Imagine your gut (and other parts of your body) is lined with a thick, sticky layer of mucus. Think of this mucus not just as a barrier, but as a giant, sticky trampoline made of sugar-coated proteins called mucins.

For a long time, scientists thought this trampoline was just a physical wall to keep bad bacteria out. But this paper explores a fascinating new idea: What if the trampoline is also a playground for viruses that eat bacteria (phages)?

The researchers studied a specific bad bacteria (Yersinia enterocolitica, which causes food poisoning) and a specific virus (a phage named fMtkYen801) that hunts it. They wanted to see how the "sticky trampoline" (mucin) changes the game between the hunter and the prey.

---

The Key Characters

1. The Prey (Yersinia): A nasty bacteria that causes gut infections.
2. The Hunter (Phage fMtkYen801): A virus that only eats this specific bacteria. It has a special "sticky hook" on its head (an Ig-like domain) that lets it grab onto the mucus.
3. The Environment (Mucin): The gooey substance that lines our guts.

---

The Surprising Discoveries

The researchers set up experiments to see what happens when these three characters interact. Here is what they found, explained simply:

1. The Hunter Gets a "Home Field Advantage"

The phage has a special hook that lets it stick to the mucus.

• The Analogy: Imagine the phage is a fisherman. Without mucus, the fisherman is standing on a slippery boat in the middle of a lake, trying to catch fish. With mucus, the fisherman is standing on a dock right next to the fish.
• The Result: The phage sticks to the mucus much better than to plain water. This confirms the "BAM model" (Bacteriophage Adherence to Mucus), which suggests phages use mucus to wait closer to their prey.

2. The Prey Gets "Tricked" into a Trap

This was the biggest surprise. The researchers let the bacteria hang out in the mucus before introducing the virus.

• The Analogy: Imagine the bacteria are like a group of soldiers. When they are in the mucus, the mucus acts like a free buffet and a chemical signal. The bacteria get excited, start eating the mucus sugars, and change their behavior. They think, "Oh, we are safe here, let's relax and grow!"
• The Result: Because the bacteria relaxed and grew faster in the mucus, they actually became more vulnerable to the virus. When the virus arrived, it found a huge, happy crowd of bacteria and replicated explosively (2-log increase!). The mucus didn't protect the bacteria; it accidentally made them easier to hunt.

3. The "Biofilm" Shield Crumbles

Bacteria often build "fortresses" called biofilms to protect themselves from viruses and antibiotics.

• The Analogy: Think of a biofilm as a castle made of slime.
• The Result: When the bacteria were in the mucus, they stopped building their castles. The mucus seemed to tell them, "You don't need a fortress; we are already in a safe, gooey environment." Consequently, the bacteria stayed in a "planktonic" state (swimming freely), which made them easier for the phages to catch and kill.

4. Temperature Matters (The "Winter Coat" Problem)

The bacteria behave differently at body temperature (37°C) vs. room temperature (25°C).

• The Analogy: At room temperature, the bacteria wear a "winter coat" (O-antigen) that the virus uses as a handle to grab them. At body temperature, the bacteria take off the coat because they don't need it.
• The Result: The virus couldn't grab the bacteria at body temperature because the "handle" was gone. This explains why this specific phage might work better in cooler parts of the body or in the environment, but struggles in the warm human gut unless the bacteria are tricked into keeping the coat on.

5. The Evolutionary Trade-Off (The "Super-Resistant" Mutants)

The researchers let the bacteria fight the virus for a while to see how they evolved. Some bacteria survived by mutating.

• The Analogy: To survive the virus, the bacteria had to cut off their own "winter coat" (the O-antigen).
• The Result: While this made them immune to the virus, it came with a heavy price. Without the coat, they became weaker in other ways. They lost their ability to move well, had trouble sensing their environment, and ironically, started building stronger biofilm fortresses to compensate for their new weakness. It's a classic "survival trade-off": you survive the virus, but you lose your agility and strength.

---

Why Does This Matter?

This study tells us that phage therapy (using viruses to cure bacterial infections) is much more complicated than just "dropping a virus on a bug."

• The Gut is a Complex World: You can't just treat the gut like a test tube. The mucus lining changes how bacteria act, how they grow, and how they fight back.
• Timing is Everything: If you give a phage treatment, the bacteria might be "relaxed" by the mucus and easier to kill. But if the bacteria adapt to the mucus first, they might change their behavior in unexpected ways.
• Future Hope: Understanding these rules helps scientists design better treatments. Maybe we can use "prebiotics" (food for good bacteria) to thicken the mucus layer, making it harder for bad bacteria to hide, while simultaneously helping the phages find their prey.

In a Nutshell

The mucus in our guts isn't just a wall; it's a dynamic stage that changes the script of the battle between bacteria and viruses. Sometimes, the mucus helps the bacteria grow, but in doing so, it accidentally sets them up to be eaten by the virus. It's a delicate, complex dance that scientists are just starting to understand.

Technical Summary

1. Problem Statement

The study addresses a critical gap in understanding the Bacteriophage Adherence to Mucus (BAM) model. While it is established that certain phages can bind to mucin glycoproteins via immunoglobulin-like (Ig-like) domains to provide a layer of mucosal immunity, the specific impact of mucins on phage-host infection dynamics, bacterial adaptation, and biofilm formation in physiologically relevant environments remains poorly understood. Specifically, the authors sought to determine how mucin supplementation, varying phage doses, temperature, and nutrient conditions influence the interaction between the highly pathogenic enteric bacterium Yersinia enterocolitica (serotype O:8) and its newly isolated, mucin-adherent phage, fMtkYen801.

2. Methodology

The researchers employed a multi-faceted approach combining in silico genomics, structural biology, and extensive in vitro experimentation:

• Phage Characterization:

  • Genomics: The genome of fMtkYen801 (92,588 bp) was sequenced and annotated.
  • Structural Prediction: In silico analysis identified an Ig-like domain-containing protein (ORF 9). AlphaFold2 was used to predict its structure, revealing a $\beta$-sandwich scaffold with positively charged patches suitable for binding negatively charged mucin glycans.
  • Phylogeny: Sequence and structural comparisons (using Foldseek) were made against known mucin-binding phages (e.g., FCL-2, T4-like phages).
  • Binding Assay: An in vitro assay measured phage retention on agar plates coated with 1% porcine gastric mucin (PGM) versus standard LB agar.

• Infection Dynamics Experiments:

  • MOI Dependence: Y. enterocolitica O:8 was infected with fMtkYen801 at Multiplicities of Infection (MOI) of 0.1, 0.01, and 0.001 in media with varying mucin concentrations (0–0.2%). Growth was monitored via optical density (OD600) over 60 hours.
  • Environmental Factors: Experiments tested the effects of temperature (25°C vs. 37°C) and nutrient availability (LB vs. nutrient-deprived dH₂O).
  • Pre-adaptation: Bacteria and/or phages were pre-exposed to mucin for 2 hours prior to co-culture to simulate mucosal colonization.

• Biofilm Analysis:

  • Biofilm biomass was quantified using Crystal Violet (CV) staining under static conditions with varying mucin and nutrient levels.
  • Bacteriophage Insensitive Mutants (BIMs): Resistant bacterial strains were isolated from co-cultures (with and without mucin) and compared to the ancestral strain regarding biofilm formation.

• Comparative Genomics:

  • Whole-genome sequencing (Nanopore + DNBseq) was performed on ancestral and BIM strains.
  • Variant calling and annotation (using Prokka, SnpEff, KEGG) identified mutations associated with phage resistance, virulence, and metabolism.

3. Key Contributions

• Validation of Mucin Binding: Confirmed that phage fMtkYen801 possesses a functional Ig-like domain that facilitates specific binding to mucin glycoproteins, validating the BAM model for this specific Yersinia-phage system.
• Decoupling Retention from Replication: Demonstrated that while mucin enhances phage retention on surfaces, it does not necessarily correlate with increased phage replication rates in liquid culture, challenging a simple interpretation of the BAM model.
• Mucin as a Physiological Cue: Revealed that pre-exposure of bacteria to mucin significantly alters their susceptibility to phage infection and modulates biofilm formation, acting as an environmental signal rather than just a physical barrier.
• Genomic Trade-offs: Identified specific genomic mutations in phage-resistant mutants that suggest fitness trade-offs between phage resistance, antibiotic resistance, and virulence.

4. Key Results

• Phage Structure and Binding:

  • fMtkYen801 contains an Ig-like domain (ORF 9) with high structural similarity to known mucin-binding phages.
  • The phage showed a 1.64-fold increase in retention on mucin-coated surfaces compared to controls ($p=0.000058$).

• Infection Dynamics (MOI and Mucin):

  • High MOI (0.1): Mucin-supplemented cultures showed earlier recovery of bacterial growth (starting at 36h vs. 48h in controls) and significantly higher final cell densities.
  • Low MOI (0.01, 0.001): Mucin supplementation led to suppressed bacterial recovery and lower final cell densities compared to controls.
  • Phage Titers: Interestingly, phage replication (PFU/mL) was not significantly altered by mucin, suggesting the observed growth differences are due to bacterial physiological changes rather than altered viral production.

• Environmental Modulation:

  • Temperature: Phage infectivity was significantly reduced at 37°C compared to 25°C. This is attributed to the temperature-dependent expression of the O-antigen (O-ag), which serves as the phage receptor.
  • Nutrient Deprivation: In nutrient-poor conditions (dH₂O), phage-infected cultures pre-adapted to mucin showed higher cell densities than non-infected controls. The authors hypothesize that phage-induced lysis released intracellular nutrients that supported the growth of resistant subpopulations, or that phages modified mucin to release nutrients.

• Biofilm Formation:

  • Mucin supplementation reduced biofilm biomass in both ancestral and phage-resistant strains.
  • BIMs (Resistant Strains): Mutants resistant to fMtkYen801 exhibited significantly higher biofilm formation than the ancestral strain, indicating a trade-off where resistance mechanisms (likely receptor loss) promote biofilm adherence.

• Genomic Analysis of Resistance:

  • Shared Mutations: 95% of mutations were shared between BIMs from mucin and non-mucin groups, indicating phage pressure is the primary driver.
  • Key Targets:
    • O-Antigen Genes: Nonsense mutations in manC_1 and missense mutations in gmd (involved in LPS O-antigen biosynthesis) were found, confirming receptor loss as the resistance mechanism.
    • Virulence & Metabolism: Mutations were found in pdeR (quorum sensing/biofilm), mrcB (peptidoglycan synthesis), and various ABC transporters (metI, gltJ, yecS, btuD, fhuC).
    • Antibiotic Resistance: Mutations in degP (linked to cationic antimicrobial peptide resistance) suggest potential cross-resistance to antibiotics.

5. Significance

This study provides crucial insights into the complexity of phage therapy within the gut environment:

1. Context-Dependent Outcomes: The efficacy of phage therapy is not static; it is heavily influenced by mucin presence, temperature, and nutrient availability. Mucin can paradoxically enhance bacterial survival at high MOIs while suppressing it at low MOIs.
2. Therapeutic Implications: The finding that mucin reduces biofilm formation is promising for treating mucosal infections, as biofilms are a major barrier to treatment. However, the emergence of phage-resistant mutants with enhanced biofilm capabilities and potential antibiotic resistance trade-offs highlights the risk of resistance evolution.
3. Physiological Relevance: The results underscore the necessity of testing phage-bacteria interactions in complex, physiologically relevant models (including mucin and varying temperatures) rather than standard nutrient broths, to accurately predict therapeutic outcomes for enteric pathogens like Y. enterocolitica.
4. Mechanistic Insight: The study clarifies that while phage adherence to mucus is a key feature of the BAM model, the downstream effects on bacterial physiology (growth, biofilm, resistance) are driven by complex host responses to the mucosal environment, not just increased local phage concentration.